11/04/2026
The QAnxiety Lab at Queen’s University is recruiting participants for a research study investigating Trigeminal Nerve Stimulation (TNS) as a potential treatment approach for individuals with treatment-resistant GAD.
TNS is a non-invasive neurostimulation technique that uses mild electrical stimulation through electrodes placed on the forehead.
In this study, participants will use a stimulation device at home overnight, alongside their usual anxiety treatment.
Who can participate?
1. Adults aged 18–65 years.
2. Diagnosed with generalized anxiety disorder (GAD).
3. Have tried at least two medications from different drug classes for GAD, without adequate improvement.
4. Currently taking a stable dose of an SSRI or SNRI for at least 8 weeks.
What are we hoping to learn?
This 10-week feasibility study will primarily evaluate the safety and tolerability of TNS in individuals with treatment-resistant GAD. We will also monitor changes in anxiety symptom severity throughout the study to better understand its potential as an additional treatment approach.
Participation involves 8 weeks of at-home TNS treatment, with study assessments throughout. Compensation is provided.
Interested in learning more or participating?
📧 Email: [email protected]
🌐 QAnxiety Lab: https://lnkd.in/eZsKJxqZ